Stay updated on Safety & Metabolic Profile of Vyvanse in ADHD & Bipolar Adults Clinical Trial
Sign up to get notified when there's something new on the Safety & Metabolic Profile of Vyvanse in ADHD & Bipolar Adults Clinical Trial page.

Latest updates to the Safety & Metabolic Profile of Vyvanse in ADHD & Bipolar Adults Clinical Trial page
- CheckyesterdayChange DetectedThe new screenshot shows minor formatting and layout adjustments on the Study Details page, with no changes to core content such as eligibility criteria, primary outcomes, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

 - Check8 days agoNo Change Detected
 - Check30 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference5%

 - Check37 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0. This signals a software update; no other content changes are indicated.SummaryDifference0.1%

 - Check51 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the Back to Top link was removed.SummaryDifference0.3%

 - Check58 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%

 - Check65 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new topics related to MedlinePlus and various chemical classifications. Notably, several previous topics and terms have been removed, indicating a shift in focus.SummaryDifference5%

 
Stay in the know with updates to Safety & Metabolic Profile of Vyvanse in ADHD & Bipolar Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Metabolic Profile of Vyvanse in ADHD & Bipolar Adults Clinical Trial page.